BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38516685)

  • 1. Clinical analysis of metaplastic breast carcinoma with distant metastases: A multi‑centre experience.
    Püsküllüoğlu M; Swiderska K; Konieczna A; Streb J; Grela-Wojewoda A; Rudzinska A; Dobrzańska J; Pacholczak-Madej R; Mucha-Malecka A; Kunkiel M; Mitus JW; Jarząb M; Ziobro M
    Oncol Lett; 2024 May; 27(5):198. PubMed ID: 38516685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaplastic breast cancer: prognosis and response to systemic therapy.
    Rayson D; Adjei AA; Suman VJ; Wold LE; Ingle JN
    Ann Oncol; 1999 Apr; 10(4):413-9. PubMed ID: 10370783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease.
    Takala S; Heikkilä P; Nevanlinna H; Blomqvist C; Mattson J
    Breast J; 2019 May; 25(3):418-424. PubMed ID: 30925636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
    Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
    PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
    Wen HY; Krystel-Whittemore M; Patil S; Pareja F; Bowser ZL; Dickler MN; Norton L; Morrow M; Hudis CA; Brogi E
    Cancer; 2017 Jan; 123(1):131-137. PubMed ID: 27526056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
    Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
    Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
    Falck AK; Fernö M; Bendahl PO; Rydén L
    BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
    Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.
    Bitencourt A; Rossi Saccarelli C; Morris EA; Flynn J; Zhang Z; Khan A; Gillespie E; Cahlon O; Mueller B; Cuaron JJ; McCormick B; Powell SN; Plitas G; Razavi P; Pinker K; Riedl CC; Sutton EJ; Braunstein LZ
    JAMA Netw Open; 2020 Oct; 3(10):e2018790. PubMed ID: 33034638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours.
    Rakha EA; Tan PH; Shaaban A; Tse GM; Esteller FC; van Deurzen CH; Purnell D; Stotter A; Chan T; Yamaguchi R; Dodwell D; Jager A; Soler MT; Juneinah E; Plaza ML; Hodi Z; McCulloch T; Lee AH; Ellis IO
    Breast; 2013 Feb; 22(1):13-8. PubMed ID: 23084962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
    Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
    Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
    Meattini I; Livi L; Saieva C; Franceschini D; Scotti V; Mangoni M; Loi M; Di Brina L; Zei G; Bonomo P; Greto D; Gelain E; Nori J; Sanchez LJ; Orzalesi L; Bianchi S; Biti G
    Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation.
    Ieni A; Barresi V; Caltabiano R; Cascone AM; Del Sordo R; Cabibi D; Zeppa P; Lanzafame S; Sidoni A; Franco V; Tuccari G
    Onco Targets Ther; 2014; 7():1267-72. PubMed ID: 25050068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma.
    Qiu Y; Chen Y; Zhu L; Chen H; Dai Y; Bao B; Tian L; Hao X; Wang J
    Breast J; 2022; 2022():2500594. PubMed ID: 36051469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.